CONMED amends credit agreement to add USD 450 million delayed-draw term loan facility
CONMED
CONMED CNMD | 0.00 |
- CONMED entered a first omnibus amendment to its June 2025 credit agreement on May 27, 2026, adding a USD 450 million delayed-draw Term A-2 facility.
- New term loan available in a single drawing through June 14, 2026; maturity June 10, 2030, matching existing revolving and term facilities.
- Proceeds earmarked to repurchase part of its outstanding 2.25% Convertible Senior Notes due 2026; covers related fees and expenses.
- Pricing set at adjusted term SOFR plus 1.125%-2.25% or base rate plus 0.125%-1.25%, tied to senior secured leverage.
- Initial margins through the first post-September 30, 2026 adjustment set at 1.75% over adjusted term SOFR or 0.75% over base rate.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CONMED Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002077096-26-000190), on June 01, 2026, and is solely responsible for the information contained therein.
